In Aβ25–35-induced AD and other brain injuries induced by glucose/oxygen deprivation or hypoxia injury, H19 silencing inhibits the expression of Bax and caspase-3, as well as promotes Bcl-2 expression, thereby inhibiting apoptosis [20,22,24]. Here, BAX is linked to Alzheimer disease.